Refine by
Sars Cov 2 Insight Research Assay For Sars Cov 2 Suppliers & Manufacturers
82 companies found
based inGeumcheon-gu, SOUTH KOREA
Since KogeneBiotech was founded in 2000, and our company has earned a reputation for innovation in Molecular Diagnostics. Our main business units are the production of Real-time PCR/conventional assay based on the active R&D works and testing ...
PowerChek SARS-CoV-2, Influenza A&B, RSV Multiplex Real-time PCR Kit II provides the fast and accurate testing solution for of nucleic acid from SARS-CoV-2 that causes Coronavirus Disease 2019 (COVID-19), Influenza A virus, Influenza B virus, ...
based inLublin, POLAND
BioMaxima S.A. is a Polish company listed on GPW Main Market, producer of microbiology media as well as a wide range of reagents and in vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics ...
Rapid chromatographic immunoassay for the qualitative detection of specific antigens to SARS-CoV-2 present in human nasopharynx. Result in: 15-30 minutes. Simple procedure. Specimen: nasopharyngeal swab. Sensitivity and specificity: As recommended ...
based inPleasanton, CALIFORNIA (USA)
Anchor Molecular is a life science diagnostics company specializing in the development of best-in-class quality controls, reference materials, and reagents for liquid biopsy assays. We focus on liquid biopsy cancer diagnostic test based on cell-free ...
The Anchor SARS-COV-2 Quality Controls contain a non-pathogenic recombinant RNA virus. This allows for the monitoring of the entire testing process, from the extraction of viral RNA to the end result of the nucleic acid amplification. The virus ...
based inSouthampton, UNITED KINGDOM
Synairgen is a drug discovery and development company founded by University of Southampton Professors Sir Stephen Holgate, Donna Davies and Ratko Djukanovic. The business, focused primarily on COVID-19, severe asthma and COPD, discovers and develops ...
based inMilford, MASSACHUSETTS (USA)
SeraCare is a leading partner and supplier of diagnostic quality controls, biological materials, and reagents to in vitro diagnostics developers, clinical laboratories, and life science researchers worldwide. Since the early 1980s, we have supported ...
The AccuPlex™ SARS-CoV-2 Verification Panel – Full Genome contains three different concentrations of positive reference material for the entire SARS-CoV-2 genome. Also includes negative reference material directed against the human RNase ...
based inBarcelona, SPAIN
Cytes Biotechnologies is a biotechnological company that offers products and services (CRO) based on tissue procurement, cell isolation and cell solutions for in vitro models addressed to the research community worldwide. The company’s main focus ...
based inDaedeok-gu, SOUTH KOREA
Bioneer, an innovative biotech company since 1992. Healthier Future for Humanity with Genomic Technology. Bioneer was the first Korean biotechnology company when it was established in 1992. The company has developed state of art molecular biology ...
AccuPower SARS-CoV-2 Variant ID2 Real-Time RT-PCR Kit(Mastermix type) is an in vitro diagnostic kit that helps diagnose SARS-CoV-2 variants. The spike gene (S gene) is the key region to monitor the mutants with the recent arising from emergence ...
based inMelbourne, AUSTRALIA
TBG Diagnostics Limited (TDL) is a global molecular diagnostics company dedicated to the development, manufacture and marketing of molecular diagnostics kits, instruments and services. With its research and development based in the US, Taiwan and ...
ExProbe SARS-CoV-2 Testing Kit is used for qualitative detection of the RdRP, N and E genes of SARS-CoV-2 in pharyngeal swabs and sputum samples. The test results of this kit can qualitatively determine whether the suspected patient is infected with ...
based inGembloux, BELGIUM
Based in Belgium and established in 1996, Coris BioConcept is a middle-sized company (SME) specialized in developing, manufacturing and marketing rapid diagnostic kits for the detection of human respiratory, gastro-enteric and blood-borne pathogens ...
In vitro rapid diagnostic test for the detection of SARS-CoV-2 antigen in nasopharyngeal secretions. Since many months, several variants did pop-up from countries where the pandemic was particularly active (i.e. UK, Brazil, India and South Africa) ...
based inXiamen, CHINA
Founded in 2004 with a registered capital of US$ 130 million, Triplex International Biosciences (China) Co., Ltd. (TIB) is a high-tech biomedical enterprise which integrates R&D, production and sales of molecular diagnosis and the supporting ...
The SARS-CoV-2 & Flu A+B Antigen Combo Rapid Test Kit, provided by Triplex International Biosciences, is a diagnostic tool designed for quick identification of SARS-CoV-2, influenza A, and influenza B viruses. This kit utilizes an in vitro ...
based inXi`an, CHINA
Since its establishment in 1997, Tianlong has been committed to the research and development, production and overall solutions of instruments and reagents in field of genetic testing and molecular diagnostics. With its own sustainable development ...
based inBryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
based inTempe, ARIZONA (USA)
GenoSensor Corporation is a genomic technology company, aiming to improve human healthcare by developing and marketing products and services for genomic research, drug discovery, predisposition gene screening, therapeutic assessment and other ...
based inPoecking, GERMANY
BioeXsen develops products for rapid pathogen diagnosis with molecular biotechnology tools in the area of human health with the production and distribution of immunobiological and isopathic medicinal products in human biology. BioeXsen SARS-CoV-2 ...
Targets three conserved SARS-CoV-2 genome regions (ORF1ab + N + E) that have not been mutated. More target region in a single channel (FAM) boosts the performance of the ...
based inFrederick, MARYLAND (USA)
SteraMist is a powerful EPA-registered disinfection and decontamination product that is designed for flexibility and reliability. SteraMist’s advanced ionized Hydrogen Peroxide (iHP) technology allows for total disinfection and protection, while ...
based inCuarte de Huerva (Zaragoza), SPAIN
OPERON was established 1973 as a private R&D laboratory in the field of immunochemistry. Initially, the target of the company was to satisfy the needs of the Spanish market. Three years later, the strategy changed focusing on the international ...
based inVirum, DENMARK
Immudex was created in 2009 when it spun off from the diagnostic company Dako, now Agilent. Since then, Immudex has grown in numbers, employees, patents, product lines, partnerships, and customers served. Research, development, and commercial ...
Reliable Identification of SARS-CoV-2-Specific T-Cell Responses. T Cells Take the Lead in COVID-19. A deeper understanding of viral-specific T-cell responses to COVID-19 is needed to explore vaccine responses, long-term immunity, predict patients at ...
based inUlm, GERMANY
Digital health offers, networked testing and vaccination infrastructure solutions. We are there with the vaccination bus and offer the opportunity to have Sars-CoV-2 antibodies determined. The result is delivered digitally as usual, if desired ...
based inRedwood City, CALIFORNIA (USA)
Telomere Diagnostics, Inc. (TDx) is a privately held DNA testing company committed to helping people improve their health. TDx's lab in Silicon Valley (Redwood City, California) is CLIA-certified under the Clinical Laboratory Improvement Amendments ...
based inRockville, MARYLAND (USA)
Tetracore is a biotechnology research and development organization that creates innovative kits, assays, reagents, and instruments for the detection of infectious diseases, biological warfare (BW) threat agents, and biological markers. Our solutions ...
EZ™-SARS-CoV-2 Real-Time RT-PCR is a real-time RT-PCR test intended for the qualitative detection of RNA from the SARS-CoV-2 in human nasal swab specimens from individuals suspected of COVID-19 by their healthcare provider. Testing is limited ...